Facebook
Twitter
LinkedIn
Forward
0628_SHSO_Optimizing Glycemic Control_Live
Overview
Description:
Hospitalized patients experiencing severe hypoglycemia and/or hyperglycemia events have increased mortality, length of stay, infection rates, and adverse complications. Severe hypoglycemia and severe hyperglycemia are two measures that are added to the quality measures of the Centers for Medicare & Medicaid Services (CMS) in 2025. Studies showed that implementing an inpatient standardized glycemic control protocol improves patient outcomes and increase adherence to meet the CMS quality measures. This grand rounds lecture serves to address the need to implement glycemic control protocols in all patient care departments and not just the ICU. This is a system-wide protocol, beginning at SRMC and expanding through SMCS with the hope of extending to all Sutter Health hospitals.
Target Audience
Pharmacists (PharmD)
Learning Objectives
By the end of this activity, learners will be able to:
1. Describe the impact of glycemic control on hospitalized patients
2. Summarize the CMS quality measures for hypoglycemia and hyperglycemia
3. Utilize the Glycemic Control per Pharmacy Protocol for MICU patients at SMCS
4. Identify the pharmacist’s role in improving glycemic control and meeting CMS standards
5. Explain the benefits of inpatient glycemic control protocol
Program
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Venkatraman S, Echouffo-Tcheugui JB, Selvin E, Fang M. Trends and Disparities in Glycemic Control and Severe Hyperglycemia Among US Adults With Diabetes Using Insulin, 1988-2020. JAMA Netw Open. 2022;5(12):e2247656. doi:10.1001/jamanetworkopen.2022.47656
Faculty
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Kerri Maya, PhD(c), MSL, RN, NPD-BC
Phipson Wu, PharmD, BCPS
Alice Nguyen, PharmD
Accreditation
Accreditation
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.00 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Attendance & Credit Claiming
Text the 6-letter attendance verification code to (916) 866-7913 to claim credit.
Available Credit
- 1.00 ACPE
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Live activity for a maximum of 1.00 of ACPE credit(s). Credits for pharmacists and technicians will be transmitted to CPE Monitor and will be available within 60 days post-activity pending submission of individual NABP e-PID and DOB (mm/dd only). Learners should claim only the credit commensurate with the extent of their participation in the activity.
